This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Assessment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In determining management is helpful to consider various points.

Severity of depression: mild, moderate or severe, determined mainly on the basis of the degree of low mood, but other factors should be taken into account. For example the presence of psychomotor retardation would exclude the description of "mild" depression. The presence of delusions indicates that the depressive illness is severe. Is there a suicide risk?

The presence of vegetative or biological symptoms: antidepressant drugs are likely to be effective if these symptoms are present.

The presence of delusions and/or hallucinations: purely psychological treatments and antidepressant drugs alone may not be sufficient. Antipsychotic drugs can be given in addition to antidepressants. However, the presence of these symptoms predicts good response to ECT.

The course of the illness: in particular whether there have been periods of abnormally high mood or frank manic episodes. If these have been present at any time, the patient is said to have a bipolar affective disorder. The implication of this for treatment is two-fold: firstly, in treating the current depression there is a danger of precipitating mania; and secondly prophylactic treatment with lithium may be indicated once the patient is no longer depressed.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.